The BIA has coined the term ‘Deep Biotech’ to capture companies working in this biotech space. This report aims to shine a light on some of the innovative companies using engineering biology to positively disrupt the environmentally damaging industries that modern society relies on.
Despite the global economic downturn, UK life sciences companies secured £1.25 billion in venture financing, constituting 11% of the total venture capital investment in UK companies this year.
The BIA has submitted a representation to HM Treasury ahead of the Spring Budget scheduled for March.
An overview of the BIA's influencing work on behalf of the innovative life science and biotech sector between October 2023 and January 2024.
The BIA has responded to the Department for Business and Trade’s call for evidence on smarter regulation and the regulatory landscape
This webinar provides an overview of the current landscape, areas of growth and investment, where to find training opportunities and the types of careers available across a broad spectrum of technologies including complex therapies, advanced manufacturing, data driven drug discovery and more.